The combination of osimertinib and chemotherapy successfully enabled surgical resection of locally advanced lung adenocarcinoma: a Case Report
Frontiers in Pharmacology · 12.05.2026 · 17
DOI: 10.3389/fphar.2026.1695807 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.05.2026. Verfasst von Cheng-Yi Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
We present the case of a 33-year-old female with a 4.3 × 3.2 cm high-density mass in the apical segment of the right upper lobe, detected on non-contrast chest CT, which showed suspected invasion of the chest wall and other tissues. CT-guided lung biopsy confirmed lung adenocarcinoma, and genetic testing revealed an EGFR exon 19 deletion. The patient received neoadjuvant therapy with oral Osimertinib combined with chemotherapy. After 4 months of treatment, she underwent thoracoscopic right upper lobectomy, mediastinal lymph node dissection, and pleural adhesion lysis. Postoperative management included anti-infection therapy, expectorants, nebulization, and analgesia. The patient recovered well and was discharged on postoperative day five, with good general condition at follow-up. This case illustrates that neoadjuvant targeted therapy combined with chemotherapy can convert locally unresectable lung cancer to a resectable status and improve operative feasibility, thus offering valuable insights for clinical management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiothoracic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Zitieren
APA
Lin, C. Y., Zhang, Q. X., Li, D., Zeng, T., Zhang, J., Guo, Q., Luo, X. Y., & Liu, T. (2026). The combination of osimertinib and chemotherapy successfully enabled surgical resection of locally advanced lung adenocarcinoma: a Case Report. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1695807
Vancouver
Lin CY, Zhang QX, Li D, Zeng T, Zhang J, Guo Q, et al. The combination of osimertinib and chemotherapy successfully enabled surgical resection of locally advanced lung adenocarcinoma: a Case Report. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1695807
BibTeX
@article{Lin2026,
author = {Lin, Cheng-Yi and Zhang, Qun-Xian and Li, Dan and Zeng, Tao and Zhang, Jun and Guo, Qiang and Luo, Xiang-Yu and Liu, Tao},
title = {The combination of osimertinib and chemotherapy successfully enabled surgical resection of locally advanced lung adenocarcinoma: a Case Report},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1695807}
}
EUVIMED